See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636050_2021_Sio_Gene_Therapies_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001636050, Sio Gene Therapies Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 85,430,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 801,000 |
| 3 | remainder_Assets | 7,449,000 |
| 4 | LiabilitiesCurrent | 32,043,000 |
| 5 | LiabilitiesNoncurrent | 79,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,355,378 |
| 9 | ResearchAndDevelopmentExpense | 782,963 |
| 10 | remainder_Expenses | 4,966,093 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,320,899 |
| 13 | remainder_ComprehensiveNetIncome | 785,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 93,680,000 |
| 1 | Liabilities | 32,122,000 |
| 2 | Expenses | 31,104,434 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 61,558,000 |
| 5 | NetIncome | -27,783,535 |
| 6 | ComprehensiveNetIncome | -27,391,035 |
| 7 | BaseVar | 80,506,166 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.70 |
| 9 | EconomicCapitalRatio | 2.82 |